论文部分内容阅读
目的:在前置胎盘治疗中,采用盐酸利托君和硫酸镁两种治疗方法,对临床治疗效果进行对比。方法:选取该院2014年1~12月的60例前置胎盘孕妇作为研究对象,随机分为两组,A组30例,采用盐酸利托君治疗;B组30例采用硫酸镁治疗。对比A组和B组分别采用不同药物治疗的保胎效果以及所产生的药物不良反应。结果:盐酸利托君的保胎效果为29例(96.67%),孕龄延长了(16.3±12.1)d;硫酸镁的保胎效果为(25例)83.33%,孕龄延长了(12.5±10.1)d,对A组和B组进行对比,差异具有统计学意义,P<0.05。从用药后出血情况来看,A组出血停止26例,B组出血停止22例。A组和B组的药物不良反应类型不同,但是并不存在明显差异。A组和B组的各项指标的比较都具有统计学意义,P<0.05。结论:对于孕妇的前置胎盘进行治疗,采用盐酸利托君要比采用硫酸镁所获得的治疗效果会更好一些,值得临床上广泛应用。
OBJECTIVE: In the treatment of placenta previa, both the two methods of treatment of Rituxol Hydrochloride and Magnesium Sulfate were used to compare the clinical effects. Methods: Sixty pregnant women with placenta previa from January to December 2014 were randomly divided into two groups. Group A (n = 30) was treated with ritodrine hydrochloride. Group B (n = 30) was treated with magnesium sulfate. Contrast A and B were treated with different drugs tocolytic effect and the resulting adverse drug reactions. RESULTS: Tocopherol Hydrochloride had a higher tocolytic effect in 29 cases (96.67%) and a gestational age of (16.3 ± 12.1) d. The tocolytic effect of magnesium sulfate was 83.33% in 25 cases and 12.5 ± 10.1) d, comparing group A and group B, the difference was statistically significant, P <0.05. Bleeding from the medication point of view, A group of bleeding stopped in 26 cases, B group bleeding stopped in 22 cases. There were different types of adverse drug reactions in groups A and B, but no significant differences were found. The comparison of each index in group A and group B was statistically significant (P <0.05). Conclusion: For the treatment of pregnant women with placenta previa, the use of ritodrine hydrochloride than magnesium sulfate obtained by the treatment effect will be better, it is widely used in clinical.